FeesSafety
Pluang+

Harmonic reports 64% revenue growth in Q3 2026, raises full-year outlook to $545-$555M

Company Fundamentals
02 Nov 2026, 23:05 WIB
PRNewsWire
View Source
Bullish
Harmonic reports 64% revenue growth in Q3 2026, raises full-year outlook to $545-$555M

Harmonic Inc. posted a 64% year-over-year revenue increase to $148.8 million in Q3 2026, driven by strong growth in its Rest-of-Market segment which now accounts for 46% of total revenue. The company introduced new fiber and AI-powered products and secured a record backlog of $534 million. Following the sale of its Video business, Harmonic is focused on broadband solutions and raised its full-year 2026 revenue guidance to $545-$555 million. This growth reflects Harmonic's expanding market reach and investment in innovative broadband technology.

Harmonic's third quarter 2026 results highlight a record backlog of $534 million. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced US tech stocks, 38 rose and 111 fell. Notable movers include FIRY at USD 13.28 (+8.06%), CRSR at USD 12.62 (-8.05%) with 100% buy order activity, and UMC at USD 16.68 (-7.54%) with 99% buy order activity and a typical hold time of 43 days.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
1 hour ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
3 hours ago
FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the compa...

Market News
Bearish
5 hours ago
NVIDIA releases Cosmos recipes for advanced vehicle, robot, and surgical simulations using AI models.

NVIDIA releases Cosmos recipes for advanced vehicle, robot, and surgical simulations using AI models.

NVIDIA has published detailed implementation recipes for its Cosmos world models, enabling developers to create simulations for vehicles, robots, and surgical procedures. These recipes guide model adaptation, testing, and GPU deployment, supporting v...

Protocol Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App